Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

PD Dr. med. Marcel Wiesweg

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Certa, Franziska; Horn, Peter; Keyl, Julius; Mende, Bastian; Lueong, Smiths; Hilser, Thomas; Theurer, Sarah; Virchow, Isabel; Zaun, Yasmin; Pogorzelski, Michael; Metzenmacher, Martin; Kalkavan, Halime; Kasper, Stefan; Schuler, Martin; Wiesweg, Marcel; Zaun, Gregor
    ABO‐Blood Group Associates With Survival Outcomes in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
    In: Thoracic Cancer , Jg. 16 2025, Nr. 6, e70037
    DOI (Open Access)
  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer , Jg. 6 2025, Nr. 2, S. 307 – 322
    DOI (Open Access)
  • Möhrmann, Lino; Rostock, Lysann; Werner, Maximilian; Oleś, Małgorzata; Arnold, Jonas S.; Paramasivam, Nagarajan; Jöhrens, Korinna; Rupp, Luise; Schmitz, Marc; Richter, Daniela; Uhrig, Sebastian; Fröhlich, Martina; Hutter, Barbara; Hüllein, Jennifer; Jahn, Arne; Arlt, Marie; Möhrmann, Elena E.; Hanf, Dorothea; Gieldon, Laura; Kreutzfeldt, Simon; Heilig, Christoph E.; Teleanu, Maria-Veronica; Lipka, Daniel B.; Beck, Katja; Baude-Müller, Annika; Mock, Andreas; Jelas, Ivan; Rieke, Damian T.; Wiesweg, Marcel; Brandts, Christian; Boerries, Melanie; Illert, Anna L.; Desuki, Alexander; Kindler, Thomas; Krackhardt, Angela M.; Westphalen, C. Benedikt; Christopoulos, Petros; Apostolidis, Leonidas; Stenzinger, Albrecht; Allgäuer, Michael; Neumann, Olaf; Kerle, Irina A.; Horak, Peter; Heining, Christoph; Grosch, Heidrun; Schröck, Evelin; Hübschmann, Daniel; Fröhling, Stefan; Glimm, Hanno
    Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors
    In: Med 2025 , in press
    DOI (Open Access)
  • Roesch, Romina M; Schnorbach, Johannes; Klotz, Laura V; Griffo, Raffaella; Thomas, Michael; Stenzinger, Albrecht; Christopoulos, Petros; Allgaeuer, Michael; Schneider, Marc; Schuler, Martin; Wiesweg, Marcel; Schramm, Alexander; Bölükbas, Servet; Doerr, Fabian; Hegedüs, Balazs; Cvetkovic, Jelena; Kirchner, Marietta; Eichhorn, Martin E; Winter, Hauke; Bozorgmehr, Farastuk; Eichhorn, Florian
    NeoTRACK trial : Neo adjuvant TiRagolumab, A tezolizumab and Chemotherapy-dissection of IO-efficacy in NSCLC by longitudinal tracKing-protocol of a non-randomised, open-label, single-Arm, phase II study
    In: BMJ Open , Jg. 15 2025, Nr. 3, e096617
    DOI (Open Access)
  • Wiesweg, Marcel; Küter, Claudia; Schnorbach, Johannes; Keyl, Julius; Metzenmacher, Martin; Cvetkovic, Jelena; Saalfeld, Felix Carl; Glanemann, Franziska; Eberhardt, Wilfried; Özkan, Filiz; Theegarten, Dirk; Stenzinger, Albrecht; Darwiche, Kaid; Koschel, Dirk; Herth, Felix; Bölükbas, Servet; Winter, Hauke; Weykamp, Fabian; Wermke, Martin; Stuschke, Martin; Plönes, Till; Thomas, Michael; Schuler, Martin; Christopoulos, Petros
    Oligometastatic non-small cell lung cancer : Impact of local and contemporary systemic treatment approaches on clinical outcome
    In: International Journal of Cancer , Jg. 156 2025, Nr. 4, S. 776 – 787
    DOI (Open Access)
  • Webendörfer, Maximilian; Heinzen, Sophie; Sibbert, Christine; Leßmann, Marie-Elisabeth; Kropf-Sanchen, Cornelia; Thomas, Michael; Tufman, Amanda; Bleckmann, Annalen; Wiesweg, Marcel; Griesinger, Frank; Reitnauer, Lea; Overbeck, Tobias Raphael
    Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024 : Targeted Therapies in Non-Small Cell Lung Cancer
    In: Oncology Research and Treatment , Jg. 48 2025, Nr. 3, S. 142 – 147
    DOI (Open Access)
  • Leßmann, Marie-Elisabeth; Sibbert, Christine; Reitnauer, Lea; Heinzen, Sophie; Webendörfer, Maximilian; Overbeck, Tobias Raphael; Griesinger, Frank; Bleckmann, Annalen; Wiesweg, Marcel; Tufman, Amanda; Thomas, Michael; Kropf-Sanchen, Cornelia
    Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024 : Non-targeted therapy in Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC) and Thymic Epithelial Tumors (TET)
    In: Oncology Research and Treatment 2025 , in press
    DOI (Open Access)
  • Richlitzki, Cedric; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Pöttgen, Christoph; Hautzel, Hubertus; Eberhardt, Wilfried E. E.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
    In: Scientific Reports , Jg. 14 2024, Nr. 1, 13765
    DOI, Online Volltext (Open Access)
  • Zaun, Gregor; Borchert, Sabrina; Metzenmacher, Martin; Lueong, Smiths; Wiesweg, Marcel; Zaun, Yasmin; Pogorzelski, Michael; Behrens, Franziska; Schildhaus, Hans-Ulrich; Virchow, Isabel; Kasper, Stefan; Schuler, Martin; Theurer, Sarah; Liffers, Sven
    Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
    In: European Journal of Cancer (EJC) , Jg. 200 2024, 113540
    DOI (Open Access)
  • Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Groß, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Woelwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen
    Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations”
    In: European Journal of Cancer (EJC) , Jg. 213 2024, 115074
    DOI (Open Access)
  • Schuler, Martin; Hense, Jörg; Darwiche, Kaid; Michels, Sebastian; Hautzel, Hubertus; Kobe, Carsten; Lueong, Smiths; Metzenmacher, Martin; Herold, Thomas; Zaun, Gregor; Laue, Katharina; Drzezga, Alexander; Theegarten, Dirk; Nensa, Felix; Wolf, Jürgen; Herrmann, Ken; Wiesweg, Marcel
    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
    In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 6, S. 851 – 855
    DOI
  • Kessler, Lukas; Schwaning, Felix; Metzenmacher, Martin; Pabst, Kim; Siveke, Jens; Trajkovic-Arsic, Marija; Schaarschmidt, Benedikt; Wiesweg, Marcel; Aigner, Clemens; Plönes, Till; Darwiche, Kaid; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Theegarten, Dirk; Hamacher, Rainer; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Fendler, Wolfgang; Hautzel, Hubertus
    Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational Trial
    In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 8, S. 1188 – 1193
    DOI
  • Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Groß, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Wölwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen
    Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations
    In: European Journal of Cancer (EJC) , Jg. 207 2024, 114158
    DOI
  • Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin
    Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease
    In: Cancers , Jg. 16 2024, Nr. 6, 1174
    DOI (Open Access)
  • Illini, Oliver; Saalfeld, Felix Carl; Christopoulos, Petros; Duruisseaux, Michaël; Vikström, Anders; Peled, Nir; Demedts, Ingel; Dudnik, Elizabeth; Eisert, Anna; Hashemi, Sayed M. S.; Janzic, Urska; Kian, Waleed; Mohorcic, Katja; Mohammed, Saara; Silvoniemi, Maria; Rothschild, Sacha I.; Schulz, Christian; Wesseler, Claas; Addeo, Alfredo; Armster, Karin; Itchins, Malinda; Ivanović, Marija; Kauffmann-Guerrero, Diego; Koivunen, Jussi; Kuon, Jonas; Pavlakis, Nick; Piet, Berber; Sebastian, Martin; Velthaus-Rusik, Janna-Lisa; Wannesson, Luciano; Wiesweg, Marcel; Wurm, Robert; Albers-Leischner, Corinna; Aust, Daniela E.; Janning, Melanie; Fabikan, Hannah; Herold, Sylvia; Klimova, Anna; Loges, Sonja; Sharapova, Yana; Schütz, Maret; Weinlinger, Christoph; Valipour, Arschang; Overbeck, Tobias Raphael; Griesinger, Frank; Jakopovic, Marko; Hochmair, Maximilian J.; Wermke, Martin
    Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON) : An International Real-World Safety and Efficacy Analysis
    In: International Journal of Molecular Sciences (IJMS) , Jg. 25 2024, Nr. 7, 3992
    DOI (Open Access)
  • Schuler, Martin; Cuppens, Kristof; Plönes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Köster, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; Maes, Brigitte; Vanbockrijck, Michel; Lähnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, Clemens
    Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer : A randomized phase 2 trial
    In: Nature Medicine , Jg. 30 2024, Nr. 6, S. 1602 – 1611
    DOI (Open Access)
  • Bischoff, Philip; Reck, Martin; Overbeck, Tobias; Christopoulos, Petros; Rittmeyer, Achim; Lüders, Heike; Kollmeier, Jens; Kulhavy, Jonas; Kemper, Marcel; Reinmuth, Niels; Röper, Julia; Janning, Melanie; Sommer, Linna; Aguinarte, Lukas; Koch, Myriam; Wiesweg, Marcel; Wesseler, Claas; Waller, Cornelius F.; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Stephan-Falkenau, Susann; Trautmann, Marcel; Lassmann, Silke; Tiemann, Markus; Klauschen, Frederick; Sebastian, Martin; Griesinger, Frank; Wolf, Jürgen; Loges, Sonja; Frost, Nikolaj; Hilbrandt, Moritz; Süptitz, Juliane; Grah, Christian; Velthaus, Janna-Lisa; Kopp, Hans-Georg; Schmidt, Bernd; Horter, Susanne; Keymel, Stefanie; Aydilek, Enver; Tritchkova, Guergana; Raspe, Matthias; Papić, Dražen; Florian, Stefan; Horst, David; Wild, Peter J.; Thomas, Michael; Grohé, Christian; Bleckmann, Annalen; Wermke, Martin; Hummel, Horst-Dieter; Stratmann, Jan; Schütte, Wolfgang
    Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
    In: Journal of Thoracic Oncology , Jg. 19 2024, Nr. 5, S. 803 – 817
    DOI (Open Access)
  • Abu Sabbah, Tanja; Theurer, Sarah; Baba, Hideo Andreas; Lueong, Smiths; Rashidi Alavijeh, Jassin; Hilser, Thomas; Zaun, Yasmin; Metzenmacher, Martin; Pogorzelski, Michael; Virchow, Isabel; Pretzell, Ina; Kostbade, Karina; Treckmann, Jürgen; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Zaun, Gregor
    PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 210 2024, 114268
    DOI (Open Access)
  • Saalfeld, Felix Carl; Möller, Johanna; Christopoulos, Petros; Wenzel, Carina; Rasokat, Anna; Wang, Xuejun Alice; Vathiotis, Ioannis; König, David; Illini, Oliver; Grohé, Christian; Wiesweg, Marcel; Wesseler, Claas; Schubart, Christoph; Pelusi, Natalie; Rohde, Gernot; Overbeck, Tobias R.; Kirfel, Jutta; Alt, Jürgen; Kauffmann-Guerrero, Diego; Griesinger, Frank; Kulhavy, Jonas; Allgäuer, Michael; Klimova, Anna; Schütz, Maret; Aust, Daniela E.; Hochmair, Maximilian J.; Rothschild, Sacha I.; Syrigos, Konstantinos N.; Veluswamy, Rajwanth; Michels, Sebastian; Stenzinger, Albrecht; Jöhrens, Korinna; Wermke, Martin
    Small cell transformation in EGFR-mutated non-small cell lung cancer : DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
    In: European Journal of Cancer (EJC) , Jg. 213 2024, 115065
    DOI (Open Access)
  • Mavroeidi, Ilektra Antonia; Romanowicz, Anna; Haake, Tristan; Wienker, Johannes; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Opitz, Marcel; Nader, Michael; Hamacher, Rainer; Siveke, Jens; Winantea, Jane; Fendler, Wolfgang; Wiesweg, Marcel; Eberhardt, Wilfried; Herrmann, Ken; Theegarten, Dirk; Schuler, Martin; Hautzel, Hubertus; Kersting, David
    Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival
    In: Theranostics , Jg. 14 2024, Nr. 14, S. 5400 – 5412
    DOI, Online Volltext (Open Access)
  • Glanemann, Franziska; Wiesweg, Marcel
    Zielgerichtete Therapie des nichtkleinzelligen Lungenkarzinoms
    In: Die Onkologie , Jg. 30 2024, Nr. 9, S. 877 – 885
    DOI
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 10, S. 1540 – 1549
    DOI (Open Access)
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. 3, S. 89 – 99
    DOI
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens T.; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 8, S. 5085 – 5094
    DOI (Open Access)
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. 4, S. 140 – 150
    DOI
  • Keyl, Julius; Hosch, René; Berger, Aaron; Ester, Oliver; Greiner, Tobias; Bogner, Simon; Treckmann, Jürgen; Ting, Saskia; Schumacher, Brigitte; Albers, David; Markus, Peter; Wiesweg, Marcel; Forsting, Michael; Nensa, Felix; Schuler, Martin; Kasper, Stefan; Kleesiek, Jens
    Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
    In: Journal of Cachexia, Sarcopenia and Muscle , Jg. 14 2023, Nr. 1, S. 545 – 552
    DOI, Online Volltext (Open Access)
  • Warnecke, Eva; Salvador Comino, Maria Rosa; Kocol, Dilara; Hosters, Bernadette; Wiesweg, Marcel; Bauer, Sebastian; Welt, Anja; Heinzelmann, Anna; Müller, Sandy; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients
    In: Cancers , Jg. 15 2023, Nr. 11, 3029
    DOI, Online Volltext (Open Access)
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 11, S. 9243 – 9252
    DOI (Open Access)
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens T.; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 8, S. 4315 – 4325
    DOI (Open Access)
  • Zurloh, M.; Goetz, M.; Herold, T.; Treckmann, Jürgen-Walter; Markus, P.; Schumacher, B.; Albers, D.; Rink, A.; Rosery, V.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Ting, S.; Schmidt, H.; Stiens, R.; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    Impact of encorafenib on survival of patients with BRAFV⁶⁰⁰E-mutant metastatic colorectal cancer in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 14, S. 12903 – 12912
    DOI (Open Access)
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 8, S. 1191 – 1194
    DOI (Open Access)
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open , Jg. 8 2023, Nr. 3, 101539
    DOI (Open Access)
  • Wessolly, Michael; Stephan-Falkenau, Susann; Streubel, Anna; Wiesweg, Marcel; Borchert, Sabrina; Mairinger, Elena; Kollmeier, Jens; Reis, Henning; Bauer, Torsten; Schmid, Kurt Werner; Mairinger, Thomas; Schuler, Martin; Mairinger, Fabian D.
    Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
    In: BMC Cancer , Jg. 22 2022, Nr. 1, 46
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy , Jg. 14 2022, Nr. 12, S. 927 – 944
    DOI (Open Access)
  • Albers, David; Schmidt, Arthur; Schiemer, Moritz; Caca, Karel; Wannhoff, Andreas; Sauer, Peter; Wiesweg, Marcel; Schumacher, Brigitte; Dechene, Alexander
    Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents : A randomized controlled multicenter trial
    In: Gastrointestinal Endoscopy , Jg. 96 2022, Nr. 6, S. 970 – 979
    DOI
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open , Jg. 7 2022, Nr. 5, 100555
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports , Jg. 12 2022, Nr. 1, 17511
    DOI, Online Volltext (Open Access)
  • Scheffler, Matthias; Wiesweg, Marcel; Michels, Sebastian; Nogová, Lucia; Kron, Anna; Herold, Thomas; Scheel, Andreas H.; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Fassunke, Jana; Darwiche, Kaid; Aigner, Clemens; Schaufler, Diana; Riedel, Richard; Fischer, Rieke; Koleczko, Sophia; Schildhaus, Hans-Ulrich; Merkelbach-Bruse, Sabine; Schmid, Kurt Werner; Büttner, Reinhard; Wolf, Jürgen; Schuler, Martin
    Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
    In: Lung Cancer , Jg. 168 2022, S. 10 – 20
    DOI
  • Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Plönes, Till
    Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms
    In: Die Innere Medizin , Jg. 63 2022, Nr. 7, S. 717 – 723
    DOI
  • Janning, M.; Süptitz, J.; Albers-Leischner, C.; Delpy, P.; Tufman, A.; Velthaus-Rusik, J.-L.; Reck, M.; Jung, A.; Kauffmann-Guerrero, D.; Bonzheim, I.; Brändlein, S.; Hummel, H.-D.; Wiesweg, Marcel; Schildhaus, Hans-Ulrich; Stratmann, J.A.; Sebastian, M.; Alt, J.; Buth, J.; Esposito, I.; Berger, J.; Tögel, L.; Saalfeld, F.C.; Wermke, M.; Merkelbach-Bruse, S.; Hillmer, A.M.; Klauschen, F.; Bokemeyer, C.; Buettner, R.; Wolf, J.; Loges, S.; Simon, Ronald; Sauter, Guido; Volk, Alexander; Neumann, Jens; Weichert, Wilko; Kalhori, Naser; Lüthen, Reinhard; Stöhr, Robert; Schubart, Chistoph; Wacker, Heidemarie; Fuchs, Florian; Hartmann, Nils; Graf, Stefanie; Brandts, Christian; Wild, Peter; Demes, Melanie; Reis, Henning; Rohde, Gernot
    Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
    In: Annals of Oncology , Jg. 33 2022, Nr. 6, S. 602 – 615
    DOI (Open Access)
  • Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 Mutations
    In: Clinical Lung Cancer , Jg. 22 2021, Nr. 5, S. E668 – E672
    DOI
  • Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin
    BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
    In: European Journal of Cancer (EJC) , Jg. 149 2021, S. 211 – 221
    DOI
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021, Nr. 2, S. 579 – 591
    DOI (Open Access)
  • Schotten, Lea M.; Darwiche, Kaid; Seweryn, Michal; Yildiz, Vedat; Kneuertz, Peter J.; Eberhardt, Wilfried; Eisenmann, Stephan; Welter, Stefan; Sisson, Brianna E.; Pietrzak, Maciej; Wiesweg, Marcel; Plönes, Till; Hager, Thomas; He, Kai; Freitag, Lutz; Aigner, Clemens; Taube, Christian; Oezkan, Filiz
    DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
    In: European Journal of Cancer (EJC) , Jg. 147 2021, S. 142 – 150
    DOI
  • Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros; Merkelbach-Bruse, Sabine; Reissig, Timm M.; Laßmann, Silke; Thiel, Sebastian; Stratmann, Jan A.; Marienfeld, Ralf; Berger, Johannes; Desuki, Alexander; Velthaus, Janna-Lisa; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Michels, Sebastian; Herold, Thomas; Kramer, Michael; Herold, Sylvia; Tufman, Amanda; Loges, Sonja; Alt, Jürgen; Joosten, Maria; Schmidtke-Schrezenmeier, Gerlinde; Sebastian, Martin; Stephan-Falkenau, Susann; Waller, Cornelius F.; Wiesweg, Marcel; Wolf, Jürgen; Thomas, Michael; Aust, Daniela E.; Wermke, Martin
    Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
    In: Journal of Thoracic Oncology , Jg. 16 2021, Nr. 11, S. 1952 – 1958
    DOI (Open Access)
  • Ho, Cassandra S. L.; Tüns, Alicia I.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedus, Balazs; Schuler, Martin; Schramm, Alexander; Oeck, Sebastian
    HER2 mediates clinical resistance to the KRASG¹²C inhibitor sotorasib, which is overcome by co-targeting SHP2
    In: European Journal of Cancer (EJC) , Jg. 159 2021, S. 16 – 23
    DOI
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology , Jg. 16 2021, Nr. 1, 176
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM) , Jg. 62 2021, Nr. 12, S. 1684 – 1691
    DOI, Online Volltext (Open Access)
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer , Jg. 19 2020, Nr. 4, S. 236 – 247.e6
    DOI
  • Welt, Anja; Wiesweg, Marcel; Theurer, Sarah; Abenhardt, Wolfgang; Groschek, Matthias; Müller, Lothar; Schröder, Jan; Tewes, Mitra; Chiabudini, Marco; Potthoff, Karin; Bankfalvi, Agnes; Marschner, Norbert; Schuler, Martin; Breitenbücher, Frank
    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
    In: Cancer Medicine , Jg. 9 2020, Nr. 13, S. 4527 – 4539
    DOI, Online Volltext (Open Access)
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer , Jg. 139 2020, S. 165 – 168
    DOI
  • Wiesweg, Marcel; Schuler, Martin; Schildhaus, Hans-Ulrich
    Crizotinib in ROS1 and MET deregulated NSCLC-letter
    In: Clinical Cancer Research , Jg. 26 2020, Nr. 7, S. 1774
    DOI (Open Access)
  • Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel
    ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
    In: Lung Cancer , Jg. 149 2020, S. 10 – 16
    DOI
  • Welt, Anja; Bogner, Simon; Arendt, Marina; Kossow, Josef; Huffziger, Antonia; Pohlkamp, Christian; Steiniger, Heike; Becker, Ute; Alashkar, Ferras; Kohl, Marzena; Wiesweg, Marcel; Richly, Heike; Hense, Jörg; Scheulen, Max Ernst; Schuler, Martin; Seeber, Siegfried; Tewes, Mitra
    Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
    In: Journal of Cancer Research and Clinical Oncology 2020
    DOI (Open Access)
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
    In: European Journal of Cancer (EJC) , Jg. 140 2020, S. 76 – 85
    DOI
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers , Jg. 12 2020, Nr. 2, S. 353
    DOI, Online Volltext (Open Access)
  • Mazières, Julien; Drilon, A.; Lusque, A.; Mhanna, L.; Cortot, A. B.; Mezquita, L.; Thai, A. A.; Mascaux, C.; Couraud, S.; Veillon, R.; Heuvel, M. van den; Neal, J.; Peled, N.; Früh, M.; Ng, T. L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu, V. W.; Rothschild, S. I.; Bironzo, P.; Martinez, A.; Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, Marcel; Besse, B.; Solomon, B.; Barlesi, F.; Schouten, R. D.; Wakelee, H.; Camidge, D. R.; Zalcman, G.; Novello, S.; Ou, S. I.; Milia, J.; Gautschi, O.
    Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry
    In: Annals of Oncology , Jg. 30 2019, Nr. 8, S. 1321 – 1328
    DOI (Open Access)
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene , Jg. 38 2019, Nr. 16, S. 2953 – 2966
    DOI
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Jens; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology , Jg. 145 2019, Nr. 2, S. 445 – 455
    DOI
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
    In: Annals of Oncology , Jg. 30 2019, Nr. 4, S. 655 – 657
    DOI (Open Access)
  • Gautschi, O.; Drilon, A.; Milia, J.; Lusque, A.; Mhanna, L.; Li, B.; Sabari, J.; Cortot, A.; Besse, B.; Mezquita, L.; Solomon, B.; Thai, A.; Couraud, S.; Veilion, R.; Mascaux, C.; Barlesi, F.; Van den Heuvel, M.; Schouten, R.; Wakelee, H.; Mah, A.; Camidge, D. R.; Ng, T.; Peled, N.; Lilach, Y.; Popat, S.; Ou, S.; Zhu, V.; Velcheti, V.; Fontecedro, A. C.; Akhoundova, D.; Fruh, M.; Zalcman, G.; Gounant, V.; Novello, S.; Bironzo, P.; Felip, E.; Martinez-Marti, A.; Moro-Sibilot, D.; Rosell, R.; Karachaliou, N.; Schuler, Martin; Wiesweg, Marcel; Diebold, J.; Mazieres, J.
    Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations : New Results from the Global IMMUNOTARGET Registry
    In: Journal of Thoracic Oncology , Jg. 13 2018, Nr. Suppl. 10, S. 367
    DOI (Open Access)
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer , Jg. 19 2018, Nr. 4, S. e441 – e463
    DOI
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer , Jg. 143 2018, Nr. 7, S. 1764 – 1773
    DOI (Open Access)
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer , Jg. 17 2018, Nr. 2, S. e331 – e352
    DOI
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer , Jg. 19 2018, Nr. 6, S. e879 – e884
    DOI
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology , Jg. 12 2017, Nr. 1, S. 54 – 64
    DOI (Open Access)
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget , Jg. 8 2017, Nr. 28, S. 45898 – 45917
    DOI (Open Access)
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) , Jg. 49 2013, Nr. 15, S. 3076 – 3082
    DOI
  • Wiesweg, M.; Berchner-Pfannschmidt, Utta; Fandrey, Joachim; Petrat, Frank; de Groot, H.; Kirsch, Michael
    Rocket fuel for the quantification of S-nitrosothiols : highly specific reduction of S-nitrosothiols to thiols by methylhydrazine
    In: Free Radical Research , Jg. 47 2013, Nr. 2, S. 104 – 115
    DOI
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 204 – 204

    • Abstracts

  • Möhrmann, Lino; Rostock, Lysann; Werner, Maximilian; Wiesweg, Marcel; Glimm, Hanno; et al.
    Comprehensive molecular analysis in advanced thymic epithelial tumors uncovers germline alterations in one fifth of patients impacting therapy recommendations
    57th European Society of Human Genetics (ESHG) Conference, June 1-4, 2024, Berlin, Germany,
    In: European Journal of Human Genetics , Jg. 32 2024, Nr. Supplement 2, S. 833 – 834
    (Open Access)
  • Oezkan, F.; Webendoerfer, M.; Winantea, Jane; Wiesweg, Marcel; Metzenmacher, M.; Theegarten, Dirk; Darwiche, Kaid; Bölükbas, S.; Dörr, F.; Taube, Christian; Stuschke, Martin; Opitz, Marcel; Schuler, Martin; Eberhardt, Wilfried
    Lung Cancer in Young Adults is Associated with Advanced Disease at Diagnosis and Increased Frequency of Targetable Mutations
    In: Journal of Thoracic Oncology , Jg. 19 2024, Nr. Suppl. 10, S. S84 – S85
  • Wiesweg, Marcel; Alaffas, A.; Rasokat, A.; Saalfeld, F.C.; Rost, M.; Assmann, C.; Herster, F.; Hilbrandt, M.; Griesinger, F.; Kropf-Sanchen, C.; Reck, M.; Kulhavy, J.; Stenzinger, A.; Sebastian, M.; Schuler, Martin; Wermke, M.; Frost, N.; Kopp, H-G.; Christopoulos, P.; Scheffler, M.
    Treatment sequences in BRAF-V600-mutant non-small cell lung cancer : First-line targeted therapy versus first-line (chemo-) immunotherapy
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S827 – S828
    DOI
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.
    68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 50 2023, Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 – S489
    DOI
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. Suppl. 1, P165
  • Stickelmann, A.; Scharpenseel, H.; Siemanowski, J.; Noelle Thielert, Franziska; Wiesweg, Marcel; Nogova, L.; et al.
    Clinical characteristics and treatment outcome of FGFR1-3 fusions in patients with non-small cell lung cancer (NSCLC) : A multicenter analysis from National Network Genomic Medicine
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 146 – 147
    DOI (Open Access)
  • Kron, A.; Scheffler, M.; Wiesweg, Marcel; Hummel, H-D.; Kulhavy, J.; Gattenlöhner, S.; Kollmeier, J.; Schubart, C.; Gross, T.; Demes, M.; Keymel, S.; Joosten, M.; Merkelbach-Bruse, S.; Wölwer, C.; Oeser, K.; Zehaczek, M.; Jeratsch, U.; Wolf, J.
    Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations : Results from the RECAP study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S793 – S794
    DOI
  • Möhrmann, L.; Rostock, L.; Oles, M.; Wiesweg, Marcel; Glimm, H.; et al.; DKFZ/NCT/DKTK MASTER
    Genomics-based characterization and personalized therapy of advanced thymic epithelial tumors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 144
    DOI (Open Access)
  • Stockey, M.; Treckmann, Jürgen-Walter; Rink, A.; Schmidt, H.; Markus, Peter; Albers, David; Zaun, G.; Kostbade, K.; Hilser, T.; Pogorzeslki, M.; Baba, Hideo Andreas; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    HER2-low as potential prognostic biomarker in patients (pts) with metastatic or recurrent Gastric Cancer (GC) or esophageal-gastric junction (AEG) adenocarcinoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 117 – 118
    DOI (Open Access)
  • Richlitzki, Cedric; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Gauler, Thomas; Hautzel, Hubertus; Eberhardt, Wilfried; Darwiche, Kaid; Theegarten, Dirk; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-C
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S100 – S101
    DOI (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin
    Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S101 – S102
    DOI (Open Access)
  • Schuler, Martin H. H.; Cuppens, K.; Ploenes, T.; Vanbockrijck, M.; Wiesweg, Marcel; Darwiche, Kaid; Schramm, Alexander; Maes, B.; Hegedus, B.; Schildhaus, Hans-Ulrich; Hautzel, H.; Theegarten, Dirk; Baas, P.; Hartemink, K.; Du Pont, B.; Aigner, Clemens
    A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1404
    DOI (Open Access)
  • Petzold, A.; Dujardin, P.; Oeck, S.; Wiesweg, Marcel; Hegedüs, B.; Schuler, Martin; Grüner, Barbara M.; Schramm, Alexander
    Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC
    In: Journal of Thoracic Oncology , Jg. 17 2022, Nr. 9, S. 611
    DOI
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S15
    DOI (Open Access)
  • Tüns, A.I.; Ho, C.S.L.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedüs, B.; Schuler, Martin; Schramm, Alexander; Oeck, S.
    Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition
    In: Journal of Thoracic Oncology , Jg. 17 2022, Nr. 9, S. S586 – S587
    DOI
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 142
  • Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin
    Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 176
  • Janning, M.; Süptitz, J.; Wiesweg, Marcel; Schildhaus, Hans-Ulrich; Loges, S.; et al.; Nationales Netzwerk Genomische Medizin
    Response to treatment of uncommon EGFR mutations : a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 3 – 4
    DOI (Open Access)
  • Janning, Melanie; Sueptitz, Juliane; Forstreuter, Anika; Albers-Leischner, Corinna; Tufman, Amanda; Velthaus-Rusik, Janna-Lisa; Reck, Martin; Jung, Andreas; Bonzheim, Irina; Brändlein, Stephanie; Wiesweg, Marcel; Stratmann, Jan; Alt, Juergen; Limberg, Juliane; Saalfeld, Felix Carl; Berger, Johannes; Tögel, Lars; Buettner, Reinhard; Wolf, Juergen; Loges, Sonja
    Treatment outcome and functional characterization of uncommon EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9036 – 9036
    DOI (Open Access)
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 137
    DOI (Open Access)
  • Darwiche, Kaid; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Aigner, Clemens; Karpf-Wissel, Rüdiger
    The impact of needle choice on molecular analysis of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in NSCLC
    In: European Respiratory Journal (ERJ) , Jg. 56 2020, Nr. Suppl. 64
    DOI (Open Access)
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 15 Suppl., S. e15121
    DOI (Open Access)
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 289
    DOI (Open Access)
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology , Jg. 31 2018, Nr. Suppl. 2, S. 378
    DOI (Open Access)
  • Wiesweg, Marcel
    Predictive markers for immune checkpoint inhibitor therapy
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 12
    DOI (Open Access)
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 55
    DOI (Open Access)
  • Richly, Heike; Scheulen, Max Ernst; Wiesweg, Marcel; Abendroth, A.; Schuler, Martin; Bauer, Sebastian
    Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 118 – 119
    DOI
  • Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 92
    DOI
  • Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. 8109
    DOI
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 2 – 3
    DOI
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 263
    DOI
  • Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 30
    DOI
  • Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.
    Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Thoracic Oncology , Jg. 8 2013, Nr. Suppl. 2, S. S914 – S915
    DOI (Open Access)

    • Poster / Posterbeiträge

  • Wiesweg, Marcel; Küter, C.; Schnorbach, J.; Keyl, J.; Plönes, T.; Metzenmacher, M.; Cvetkovic, J.; Eberhardt, Wilfried E.E.; Oezkan, F.; Theegarten, Dirk; Stenzinger, A.; Darwiche, Kaid; Herth, F.J.F.; Bölükbas, S.; Winter, H.; Weykamp, F.; Stuschke, Martin; Thomas, M.; Schuler, Martin H. H.; Christopoulos, P.
    Oligometastatic non-small cell lung cancer : Impact of local and systemic treatment approaches on clinical outcome
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S828
    DOI
  • Reitnauer, L.; Evers, G.; Christoph, Daniel; Wiesweg, Marcel; Glanemann, Franziska; Webendörfer, Maximilian P.; Bleckmann, A.; et al.
    Relapse after radiochemotherapy and consolidative Durvalumab in Stage III NSCLC – a retrospective analysis in a real-world setting
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 229
    DOI (Open Access)
  • Saalfeld, F.C.; Möller, J.; Michels, S.; Grohe, C.; Wiesweg, Marcel; Schubart, C.; Alt, J.; Griesinger, F.; Kauffmann-Guerrero, D.; Kulhavy, J.; Overbeck, T.R.; Pelusi, N.; Rohde, G.; Wesseler, C.; Vathiotis, I.; Veluswamy, R.; Illini, O.M.; Rothschild, S.I.; Christopoulos, P.; Wermke, M.
    Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC) : Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S770
    DOI (Open Access)